Copyright Reports & Markets. All rights reserved.

Global Mycosis Fungoides Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Mycosis Fungoides Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Topical Steroids
      • 1.4.3 Mechlorethamine Gel
      • 1.4.4 HDAC Inhibitors
      • 1.4.5 Monoclonal Antibodies
      • 1.4.6 Localized Radiation Therapy
      • 1.4.7 Extracorporeal Photopheresis
      • 1.4.8 Others
    • 1.5 Market by Application
      • 1.5.1 Global Mycosis Fungoides Treatment Market Share by Application (2019-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Ambulatory Surgical Centers
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Mycosis Fungoides Treatment Market Size
    • 2.2 Mycosis Fungoides Treatment Growth Trends by Regions
      • 2.2.1 Mycosis Fungoides Treatment Market Size by Regions (2019-2025)
      • 2.2.2 Mycosis Fungoides Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Mycosis Fungoides Treatment Market Size by by Players
      • 3.1.1 Global Mycosis Fungoides Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global Mycosis Fungoides Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Mycosis Fungoides Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Mycosis Fungoides Treatment Key Players Head office and Area Served
    • 3.3 Key Players Mycosis Fungoides Treatment Product/Solution/Service
    • 3.4 Date of Enter into Mycosis Fungoides Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Mycosis Fungoides Treatment Market Size by Type (2014-2019)
    • 4.2 Global Mycosis Fungoides Treatment Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Mycosis Fungoides Treatment Market Size (2014-2019)
    • 5.2 Mycosis Fungoides Treatment Key Players in North America
    • 5.3 North America Mycosis Fungoides Treatment Market Size by Type
    • 5.4 North America Mycosis Fungoides Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Mycosis Fungoides Treatment Market Size (2014-2019)
    • 6.2 Mycosis Fungoides Treatment Key Players in Europe
    • 6.3 Europe Mycosis Fungoides Treatment Market Size by Type
    • 6.4 Europe Mycosis Fungoides Treatment Market Size by Application

    7 China

    • 7.1 China Mycosis Fungoides Treatment Market Size (2014-2019)
    • 7.2 Mycosis Fungoides Treatment Key Players in China
    • 7.3 China Mycosis Fungoides Treatment Market Size by Type
    • 7.4 China Mycosis Fungoides Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Mycosis Fungoides Treatment Market Size (2014-2019)
    • 8.2 Mycosis Fungoides Treatment Key Players in Japan
    • 8.3 Japan Mycosis Fungoides Treatment Market Size by Type
    • 8.4 Japan Mycosis Fungoides Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Mycosis Fungoides Treatment Market Size (2014-2019)
    • 9.2 Mycosis Fungoides Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Mycosis Fungoides Treatment Market Size by Type
    • 9.4 Southeast Asia Mycosis Fungoides Treatment Market Size by Application

    10 India

    • 10.1 India Mycosis Fungoides Treatment Market Size (2014-2019)
    • 10.2 Mycosis Fungoides Treatment Key Players in India
    • 10.3 India Mycosis Fungoides Treatment Market Size by Type
    • 10.4 India Mycosis Fungoides Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Mycosis Fungoides Treatment Market Size (2014-2019)
    • 11.2 Mycosis Fungoides Treatment Key Players in Central & South America
    • 11.3 Central & South America Mycosis Fungoides Treatment Market Size by Type
    • 11.4 Central & South America Mycosis Fungoides Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Astellas Pharma
      • 12.1.1 Astellas Pharma Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Mycosis Fungoides Treatment Introduction
      • 12.1.4 Astellas Pharma Revenue in Mycosis Fungoides Treatment Business (2014-2019))
      • 12.1.5 Astellas Pharma Recent Development
    • 12.2 Bayer AG
      • 12.2.1 Bayer AG Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Mycosis Fungoides Treatment Introduction
      • 12.2.4 Bayer AG Revenue in Mycosis Fungoides Treatment Business (2014-2019)
      • 12.2.5 Bayer AG Recent Development
    • 12.3 Dover Medical and Scientific Equipment, Ltd.
      • 12.3.1 Dover Medical and Scientific Equipment, Ltd. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Mycosis Fungoides Treatment Introduction
      • 12.3.4 Dover Medical and Scientific Equipment, Ltd. Revenue in Mycosis Fungoides Treatment Business (2014-2019)
      • 12.3.5 Dover Medical and Scientific Equipment, Ltd. Recent Development
    • 12.4 Elorac, Inc.
      • 12.4.1 Elorac, Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Mycosis Fungoides Treatment Introduction
      • 12.4.4 Elorac, Inc. Revenue in Mycosis Fungoides Treatment Business (2014-2019)
      • 12.4.5 Elorac, Inc. Recent Development
    • 12.5 Kyowa Kirin, Inc.
      • 12.5.1 Kyowa Kirin, Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Mycosis Fungoides Treatment Introduction
      • 12.5.4 Kyowa Kirin, Inc. Revenue in Mycosis Fungoides Treatment Business (2014-2019)
      • 12.5.5 Kyowa Kirin, Inc. Recent Development
    • 12.6 Macopharma
      • 12.6.1 Macopharma Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Mycosis Fungoides Treatment Introduction
      • 12.6.4 Macopharma Revenue in Mycosis Fungoides Treatment Business (2014-2019)
      • 12.6.5 Macopharma Recent Development
    • 12.7 Soligenix, Inc.
      • 12.7.1 Soligenix, Inc. Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Mycosis Fungoides Treatment Introduction
      • 12.7.4 Soligenix, Inc. Revenue in Mycosis Fungoides Treatment Business (2014-2019)
      • 12.7.5 Soligenix, Inc. Recent Development
    • 12.8 Varian Medical Systems
      • 12.8.1 Varian Medical Systems Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Mycosis Fungoides Treatment Introduction
      • 12.8.4 Varian Medical Systems Revenue in Mycosis Fungoides Treatment Business (2014-2019)
      • 12.8.5 Varian Medical Systems Recent Development
    • 12.9 Yaupon Therapeutics
      • 12.9.1 Yaupon Therapeutics Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Mycosis Fungoides Treatment Introduction
      • 12.9.4 Yaupon Therapeutics Revenue in Mycosis Fungoides Treatment Business (2014-2019)
      • 12.9.5 Yaupon Therapeutics Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Mycosis fungoides is most frequently encountered in primary cutaneous lymphoma. The disease progression is slow and indolent with a challenging diagnosis in the early stage of the disease which requires accurate clinical-histopathological correlation. It is a rare disease occurs usually in adults above 50 years of age, the ratio of its occurrence in men to women is 2:1.
      In 2018, the global Mycosis Fungoides Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Mycosis Fungoides Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mycosis Fungoides Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Astellas Pharma
      Bayer AG
      Dover Medical and Scientific Equipment, Ltd.
      Elorac, Inc.
      Kyowa Kirin, Inc.
      Macopharma
      Soligenix, Inc.
      Varian Medical Systems
      Yaupon Therapeutics

      Market segment by Type, the product can be split into
      Topical Steroids
      Mechlorethamine Gel
      HDAC Inhibitors
      Monoclonal Antibodies
      Localized Radiation Therapy
      Extracorporeal Photopheresis
      Others

      Market segment by Application, split into
      Hospitals
      Ambulatory Surgical Centers
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Mycosis Fungoides Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Mycosis Fungoides Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Mycosis Fungoides Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now